# The Safety and Efficacy of Embotrap in Treating Acute Ischemic Stroke Patients

Study · id `cardio:ct-nct05667103` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05667103](<https://clinicaltrials.gov/study/NCT05667103>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05667103

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 330 participants.

## Technical summary

Registry record NCT05667103. Randomized; quadruple masking; primary purpose treatment. Start 2023-01-15 (actual); primary completion 2024-07-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 330 participants (planned count; ClinicalTrials.gov record NCT05667103, source copy `cardio:ctgov-nct05667103-2023-11-13`, retrieved 2026-10-26)
- Started: 2023-01-15 (actual) (ClinicalTrials.gov record NCT05667103, source copy `cardio:ctgov-nct05667103-2023-11-13`, retrieved 2026-10-26)
- Primary completion: 2024-07-01 (anticipated) (ClinicalTrials.gov record NCT05667103, source copy `cardio:ctgov-nct05667103-2023-11-13`, retrieved 2026-10-26)
- Completion: 2024-07-01 (anticipated) (ClinicalTrials.gov record NCT05667103, source copy `cardio:ctgov-nct05667103-2023-11-13`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05667103, source copy `cardio:ctgov-nct05667103-2023-11-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05667103-2023-11-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Safety and Efficacy of Embotrap in Treating Acute Ischemic Stroke Patients
- Condition: Stroke
- Condition: Acute Ischemic Stroke
- Intervention (Device): Embotrap stent retriever
- Intervention (Device): Solitaire FR, Trevo stent retriever without inner channel
- Lead sponsor: Xuanwu Hospital, Beijing
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Xuanwu Hospital, Beijing (`cardio:org-xuanwu-hospital-beijing`)

## Provenance

Content hash: 16ccec26e52d714c5b3dd1f71fb7da3061ba585d1208cff631104d71dbee5522
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
